Infectious diseases are caused by organisms such as bacteria, viruses, fungi, and parasites and are capable of transmission from one species to another species. Diagnosis of these diseases involves identifying the pathogen and its type and the degree up to which the infection has spread. Infectious diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent and can be efficiently diagnosed with the help of diagnostic tests available for the respective diseases.

Technologies utilized by these diagnostic tests are classified into biochemical techniques, molecular techniques, immunodiagnostics, and conventional culturing, and staining techniques. Biochemical techniques include ELISA, agglutination, and others, while molecular techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing the infectious diseases accurately with high throughput capacity.

Advances in molecular testing techniques have resulted in fast diagnosis of infectious diseases in real-time due to which patients can receive treatment early. Commercially available diagnostic tests include BD Max Smart Cycler, GeneXpert, BD Phoenix CPO detect test, Xpert Xpress Strep A, and BioPlex 2200 Syphilis Total & RPR Assay.

Partnerships and collaborations by market players to develop novel diagnostic techniques is expected to boost growth of the infectious disease diagnostics market

Individual organizations, manufacturers, and research institutes are forming partnerships, and collaborations to advance research and development of diagnostic tests for infectious diseases. Moreover, funding by individual organizations to advance research is expected to boost the growth of the market over the forecast period. For instance, the University of Virginia’s Global Infectious Diseases Institute funded seven projects designed to tackle challenging problems in infectious diseases worldwide in July 2018. They have formed collaborative teams across diverse academic disciplines to control and treat Zika virus infections and to reduce tuberculosis rates among HIV-infected patients in Africa.  

The New York Governor’s Office announced a research collaboration with Regeneron Pharmaceuticals, Inc. to advance the diagnosis and treatment of tick-borne diseases in June 2018. Moreover, Infectious Diseases Society of America (IDSA) and American Society for Microbiology (ASM) released a guide in July 2018, which is expected to help healthcare providers to understand latest technology trends, and knowledge on when to order which test. These factors are expected to affect the growth of infectious disease diagnostic market over the forecast period.  
Global Key Players:
Key companies covered as a part of this study include Danaher Corporation, Abbott Laboratories, Becton, Dickinson, and Company, F. Hoffmann La-Roche Ltd., Trinity Biotech Plc, Cardinal Health, Inc., BioMérieux, Bio-Rad Laboratories, Inc., AccuBioTech Co., Ltd., and Acon Laboratories, Ltd.

Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/1971

Detailed Segmentation:
• Global Infectious Disease Diagnostics Market, By Product Type:
◦ Kits & Reagents
◦ Instruments
• Global Infectious Disease Diagnostics Market, By Disease Type:
◦ HIV
◦ Hepatitis
◦ Healthcare Associated Infections (HAIs)
◦ Human Papillomavirus (HPV)
◦ Tuberculosis (TB)
◦ Influenza
◦ Others
• Global Infectious Disease Diagnostics Market, By Technology:
◦ Immunodiagnostics
◦ Polymerase Chain Reaction (PCR)
◦ Next Generation Sequencing (NGS)
◦ Others
• Global Infectious Disease Diagnostics Market, By Test Location:
◦ Laboratory Testing
◦ Point-of-Care Testing
• Global Infectious Disease Diagnostics Market, By End User:
◦ Hospitals
◦ Pathology/Diagnostic Laboratories
◦ Research Institutes
◦ Home-Care Settings
◦ Others
• Global Infectious Disease Diagnostics Market, By Geography:
◦ North America
◦ Europe
◦ Asia Pacific
◦ Latin America
◦ Middle East
◦ Africa

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]